Senate Committee Accepts New Language in Bill Regarding Drug Shortages


A bill that requires drug manufacturers to report to the FDA when a shortage is on the horizon – or when a drug would be discontinued – recently received two additions that would help physicians as they battle shortages in emergency departments. ACEP, working with several other emergency care organizations, was instrumental in getting language included in the bill that states “a sterile injectable product” or “used in emergency care or during surgery” would also qualify. The legislation currently sits in the Senate Committee on Health, Education, Labor and Pensions legislation. The Senate HELP committee is scheduled to meet April 25. Similar legislation will begin working its way through the House Energy and Commerce Committee next week. The FDA reports that shortages have increased since 2010, when it listed 178 drugs that were in short supply.

  1. No comments yet.
(will not be published)

  1. No trackbacks yet.